PharmaShots | Incisive News in 3 Shots

Subscribe Now

Hypoactive Sexual Desire Disorder

Palatin Technologies' Vyleesi (bremelanotide injection) Receives FDA's Approval for Premenopausal Women with Acquired- Generalized Hypoactive Sexual Desire Disorder

Palatin Technologies' Vyleesi (bremelanotide injection) Receives FDA's Approval for Premenopausal Women with Acquired- Generalized...

June 22, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us